STEFANOS D. KOUTSOSTATHIS, MD, PhD
Personal Information
Name: Stefanos Koutsostathis
Home Address: 12 M Alexandrou str, Maroussi, Attiki, Greece , 151 22
Office:+302106502854
Secretary:+306974442788
Cell Phone: +306932487848
Email: skoutsostathis@gmail.com
Internet links:
www.koutsostathis.gr,
drstefanoskoutsostathes(instagram),
www.facebook.com/share/16yxyqHeiU/?mibextid=wwXIfr
Place of Birth: Athens, Greece
Date of Birth: April 17, 1972
Orthopedic Surgeon
Chief of the 8th, MIS Hip & Knee Arthroplasty, Orthopedic Department, Metropolitan General Hospital
Education
1991-1997: Medical School of Athens University
Pre – Residency
1998 – 1999: Military Medical Service
2000: Level I Medical Service – Chalkida General Hospital
Residency
2001-2006: 1 st IKA Hospital, Athens, Greece, O&T Department, Director: GA Macheras 1st IKA Hospital is a 320-bed General Hospital. Department of Orthopaedics and Trauma is a Level II Regional Resource Trauma Center. It is also a Referral Center for Reconstruction of Major Joints, including Revision Surgery and also for Knee Arthroscopy. As a senior resident, responsibilities included operating on trauma and elective cases under supervision and active participation in the Department’s Educational Program. Additional experience was received in Pediatric Orthopaedics (Aglaia Kyriakou Pediatric Hospital 2004) and Microsurgery (KAT Hospital 2005, including 3 months experimental training in microsurgery techniques in mice)
Post – Residency experience and Current Status
2007: Locum Consultant in Levadia General Hospital, Greece, O&T Department, Director: IP
Sofianos Levadia Hospital is a Regional Hospital that serves a 100.000 population. Responsibilities
included: Part of a twice a week emergency rotation
Regular theatre activity, twice a week: Lower and Upper Limb Trauma list, Primary Hip and Knee Reconstruction Supervision of residents (wards, operating room) Participation in the Department’s Educational Program
2008: Fellowship in Sports Medicine Clinic, KAT Hospital, Athens, Greece, Director: P Vallianatos
Sports Medicine Clinic is a distinct Clinic, focusing on the arthroscopic treatment of knee pathology: meniscal and ligamentous knee injuries, knee instability, complex cases
2009 – April 2012: Consultant of 4 th Department of Orthopaedics and Trauma, KAT Hospital, Athens, Greece. Director: GA Macheras. KAT Hospital is the largest Trauma Center in Greece (Level III Trauma Center) and also a Referral Center for Elective Surgery. Responsibilities included:
May 2012 – September 2018 Consultant of Department of Orthopaedics and Trauma, Mitera Hospital, Hygeia Group, Athens, Greece. Director: J Vlachos.
October 2018 – Currently: Director of the MIS Hip and Knee Arthroplasty Department,
Metropolitan General Hospital, Athens, Greece
Serving in the private Health Sector I focused on Hip Arthroplasty, especially AMIS Hip Atrhroplasty which I perform as a certified surgeon since 2014. AMIS is a minimal invasive method introduced by Medacta. It offers lower surgical trauma and blood loss, fast track postoperative recovery and excellent long term function and longevity of the implants. During the last decade, following my special training in this method, I have operated on an increasing number of patients per year, having also performed a considerable number of simultaneous bilateral hip arthroplasty operations in selected patients. I have also performed a considerable number of AMIS operations using navigation assistance or custom – made implants, depending on the patient's indications. The Department I direct currently perfoms more than 200 major lower limb operations per year, 65% of them being AMIS cases
Area of specialization: Hip Arthroplasty
EFORT Scholarship September 2013 – March 2014
Scrub in training, ward round participation, participated in approx. 200 AMIS operations SkyRidge Medical Center, LOANTREE USA (Official Medacta training center) April 2014 – June 2014, scrub – in training participated in approx. 200 AMIS operations
OFFICIAL USER OF THE AMIS METHOD CERTIFIED BY MEDACTA (Medacta
International, official Site, “find your doctor”)
Review Activity
Reviewer for the Official Journal of the EFFORT “European Orthopaedics and Traumatology”
since 2010
Investigation Projects
Investigator in the “Study To Assess Healing of Repaired Tibias with SclerosTin Antibody” AMG 785 (STARTT). An international multicenter prospective randomized against placebo, double – blinded Phase II Study performed by AMGEN. Participation 2009 – 2014.
Horonary Distinction
Invited, Nov 2013 – Dec 2013 by Chun Li Orthopedics in a 3 week closed seminar as a scrub – in instructor, training Orthopaedic surgeons of China Public Health System in new Hip Arthroplasty techniques (3 -4 operations and respective lectures daily)
Research
2014: PhD in Orthopaedics, Medical School, Athens University. Title: “experimental model of multiple trauma. Immune – modulation with poly-unsaturated fatty acids” grade 10/10 (excellent)Invited speaker
Author activity
Publications: 27, peer reviewed 20
1. Acetabular bone response to porous tantalum. Acta Orthopaedica et Traumatologica Hellenica 52/2
2. Frequency and effects of orthopedic pathologies in active population. Edition of Greek Community for Health Education p.88, 12/02
3. Bath- Wessex Total Ankle Replacement: Eight- year results. Acta Orthopaedica et Traumatologica Hellenica 53/4
4. Management of large acetabular bone defects. Acta Orthopaedica et Traumatologica Hellenica 54/1
5. Retrograde intramedullary nailing and mini open reduction for the treatment of delayed union and non union of humeral fractures. Acta Orthopaedica et Traumatologica Hellenica 55/2
6. Spinal metastasis of primary lung cancer. Info orthopedics (43)
7. Bone morphogenetic proteins. Theory and applications. Info orthopaedics & trauma (48)
8. 8-10 years clinical and radiographic results of a porous tantalum monoblock acetabular component. J Arthroplasty 24(5):705-9
9. TMT cups in treating patients with high congenital hip dislocation. A prospective study. J
Bone Joint Surg Br 92(5):624-8
10. The Use Of TMT ACETABULAR Component in high CHD, Journal Orthopaedic Proceedings Volume 93-B No.SUPP II Pages 87 – 87
11. Biological processes at Bone – Porous Tantalum Interface. Journal of Orthopaedics 6(4)e3
12. Treatment of a femoral shaft fracture in a patient with congenital hip disease: a case report.
Journal of Medical case reports, 22;4:221
13. Eicosapentanoic acid prolongs survival and attenuates inflammatory response in an experimental model of multiple trauma. Prostaglandins leukot essent fatty acids, 83(2):69-74.
14. The long-term results of a two-stage protocol for revision of an infected total knee replacement, J Bone Joint Surg (Br) 93-B:1487–92.
15. ARC2F acetabular component: sudden onset of rapid and massive PE insert wear in long term observation. J Bone Joint Surg Br 93-B no. SUPP II 128
16. Early increase of serum Angiopoietin-2 are associated with early progression to death in an experimental injury model, Cytokine 56(3):817-22
17. Applications of gene therapy in the treatment of osteoarthritis. A review. Journal of Orthopaedics 9(1)e12
18. The surveillance of Arc2f polyethylene after 15 years of implantation. J Bone Joint Surg (Br) Vol 23, Issue 5
19. Does PFNA II avoid lateral cortex impingement for unstable peritrochanteric fractures? CORR V470 3067 – 3076
20. Two stage re – implantation without interim cement spacer for chronic late infection of total hip arthroplasty. Mid to long term results Hip International Vol 22 Issue8 Suppl
21. Osseus integration in porous tantalum implants, Indian Journal of Orthopaedics Vol 46
505 -513
22. Which patients are at risk for kidney dysfunction after hip fracture Surgery CORR Volume
471 Issue 12
23. Reply to Letter to the Editor: Does PFNA II Avoid Lateral Cortex Impingement for Unstable
Peritrochanteric Fractures CORR Vol 471
We will send you a confirmation within 24 hours.
Emergency? Call 1-2554-2356-33
